| Smith, Ellen Mary Lavoie |
University Of Alabama At Birmingham
United States |
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study |
5R01CA235726-07 |
Brennan Streck, Ph.D., R.N., M.P.H. |
| Schenker, Yael |
University Of Pittsburgh At Pittsburgh
United States |
Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial |
5R01CA235730-06 |
Brennan Streck, Ph.D., R.N., M.P.H. |
| Dryden-Peterson, Scott Lee |
Brigham And Women'S Hospital
United States |
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation |
5R01CA236546-05 |
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
| Zheng, Yingye |
Fred Hutchinson Cancer Center
United States |
Statistical Methods for Prospective Evaluation of Biomarkers |
5R01CA236558-14 |
Nick Hodges, Ph.D. |
| Nyante, Sarah Jane |
Univ Of North Carolina Chapel Hill
United States |
Understanding the biological basis for the association between parenchymal texture features and breast cancer risk |
5R01CA237129-05 |
Christos Patriotis, Ph.D., M.Sc. |
| Pandharipande, Pari Vijay |
Ohio State University
United States |
Precision Management of Cystic Precursors to Pancreatic Cancer |
5R01CA237133-06 |
Matthew Young, Ph.D. |
| Phd, Ralph Weissleder, Md, |
Massachusetts General Hospital
United States |
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) |
5R01CA237332-04 |
Matthew Young, Ph.D. |
| Phd, Ralph Weissleder, Md, |
Massachusetts General Hospital
United States |
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) |
5R01CA237332-04 |
Matthew Young, Ph.D. |
| Phd, Ralph Weissleder, Md, |
Massachusetts General Hospital
United States |
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) |
5R01CA237332-04 |
Matthew Young, Ph.D. |
| Phd, Ralph Weissleder, Md, |
Massachusetts General Hospital
United States |
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) |
5R01CA237332-04 |
Matthew Young, Ph.D. |